40 / 1601
Where it gets a little complicated…
•
How many patients for how long?
•
When RT is a consolidation treatment vs the only treatment
modality
•
When the risks to OARs exceeds the benefit of full target
coverage
You need to know your uncertainties to make the best decision
about risk/benefits balance